阿爾特(300825.SZ):用於重卡增程器的汽油/甲醇/天然氣燃料V6發動機項目順利推進中
格隆匯7月16日丨阿爾特(300825.SZ)近日在接待機構投資者調研時表示,公司具有多年整車研發和核心零部件研發經驗,並掌握核心零部件研發製造的關鍵技術,研發、生產的主要零部件產品包括DHT總成及EDU總成、電磁離合器模塊、減速器、增程器、多合一動力總成、V6發動機(第一代、第二代)等,並前瞻儲備潛在市場需求較大的高端產品及相關技術。子公司四川阿爾特與柳州菱特已與多家車企積極洽談並取得顯著成效,部分零部件產品已獲得量產定點資質,用於重卡增程器的汽油/甲醇/天然氣燃料V6發動機項目也正在順利推進中。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.